4893 items matching your search terms.

Benefits and safety of long-term fenofibrate therapy in people with type 2 diabetes and renal impairment: The FIELD study

Ting, R. D. Keech, A. C. Drury, P. L. Donoghoe, M. W. Hedley, J. Jenkins, A. J. Davis, T. M. E. Lehto, S. Celermajer, D. Simes, R. J. Rajamani, K. Stanton, K.
DIABETES CARE, 2012     DOI:10.2337/dc11-1109

High-sensitivity CRP does not independently predict subsequent events in stable CHD patients in the Long-term Intervention with Pravastatin in Ischaemic Disease (LIPID) study

Tonkin, AM Barnes, EH Kirby, AC Nestel, P Sullivan, DR Thompson, P West, M White, HD Zeller, T Simes, RJ

Effects of fenofibrate on cardiovascular events in patients with diabetes, with and without prior cardiovascular disease: The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study

Tonkin, A Hunt, D Voysey, M Kesäniemi, A Hamer, A Waites, J Mahar, L Mann, S Glasziou, P Forder, P Simes, J Keech, AC on behalf of the FIELD study investigators,
AMERICAN HEART JOURNAL, 2012     DOI:10.1016/j.ahj.2011.12.004

Effects of fenofibrate on cardiovascular events in patients with diabetes, with and without prior cardiovascular disease: The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study

Tonkin, A. Hunt, D. Voysey, M. Kesäniemi, A. Hamer, A. Waites, J. Mahar, L. Mann, S. Glasziou, P. Forder, P. Simes, J. Keech, A. C.
AMERICAN HEART JOURNAL, 2012     DOI:10.1016/j.ahj.2011.12.004

Recruitment and results of a pilot trial of vitamin D supplementation in the general population of Australia

Tran, B Armstrong, BK Carlin, JB Ebeling, PR English, DR Kimlin, MG Rahman, B van der Pols, JC Venn, A Gebski, V Whiteman, DC Webb, PM Neale, RE
JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, 2012     DOI:10.1210/jc.2012-2682

Clinicians’ predictions of survival time and prognostic factors in patients starting first line chemotherapy for advanced non-small cell lung cancer

Trinkaus, M Davidson, A Briscoe, K Hughes, B Begbie, S Brown, C Pavlakis, N Millward, M Boyer, M Stockler, M Australasian Lung Cancer Trials Group and NHMRC Clinical Trials Centre Collaboration,

Applying project management principles to research projects in a health setting

Vachan, B

Standard 4: determining adequate sample sizes

van der Tweel, I Askie, L Vandermeer, B Ellenberg, S Fernandes, RM Saloojee, H Bassler, D Altman, DG Offringa, M van der Lee, JH
PEDIATRICS, 2012     DOI:10.1542/peds.2012-0055G

Decision making in older patients with advanced cancer: does doctor know best? [letter]

Venkateswaran, LP Butow, PN Jansen, J Wilcken, NR Wong, MK Hui, R Szonyi, G Gebski, VJ Naganathan, V Horvath, LG Tattersall, MH

Randomized phase III study of erlotinib versus observation in patients with no evidence of disease progression after first-line platin-based chemotherapy for ovarian carcinoma: A GCIG and EORTC-GCG study

Vergote, IB Joly, F Katsaros, D Coens, C Reinthaller, A Hall, M Steer, CB Colombo, N Lesoin, A Casado, A Petru, E Green, J Buck, M Ray-Coquard, IL Ferrero, A Favier, L Reed, N Curve, H Jimeno, A Pujade-Lauraine, E

Effectiveness and cost-effectiveness of sentinel lymph node biopsy compared with axillary node dissection in patients with early-stage breast cancer: a decision model analysis

Verry [Carter], H Lord, SJ Martin, A Gill, G Lee, CK Howard, K Wetzig, N Simes, J
BRITISH JOURNAL OF CANCER, 2012     DOI:10.1038/bjc.2012.62

Comorbidity, age and overall survival in patients with advanced pancreatic cancer—results from NCIC CTG PA.3: a phase III trial of gemcitabine plus erlotinib or placebo

Vickers, MM Powell, ED Asmis, TR Jonker, DJ Hilton, JF O'Callaghan, CJ Tu, D Parulekar, W Moore, MJ
EUROPEAN JOURNAL OF CANCER, 2012     DOI:10.1016/j.ejca.2011.10.035

Information on blinding in registered records of clinical trials [letter]

Viergever, RF Ghersi, D
TRIALS, 2012     DOI:0.1186/1745-6215-13-210

Final overall survival results of phase III GCIG CALYPSO trial of pegylated liposomal doxorubicin and carboplatin vs paclitaxel and carboplatin in platinum-sensitive ovarian cancer patients

Wagner, U Marth, C Largillier, R Kaern, J Brown, C Heywood, M Bonaventura, T Vergote, I Piccirillo, MC Fossati, R Gebski, V Lauraine, EP
BRITISH JOURNAL OF CANCER, 2012     DOI:10.1038/bjc.2012.307

Effect of dependent errors in the assessment of diagnostic or screening test accuracy when the reference standard is imperfect

Walter, SD Macaskill, P Lord, SJ Irwig, L
STATISTICS IN MEDICINE, 2012     DOI:10.1002/sim.4444